HIStalk Sponsor Announcements
Aprima is the only non-vein-specific EHR certified by the ACP - Printable Version

+- HIStalk Sponsor Announcements (http://histalk.com/forum)
+-- Forum: Sponsor News (http://histalk.com/forum/forumdisplay.php?fid=1)
+--- Forum: Announcements (http://histalk.com/forum/forumdisplay.php?fid=2)
+--- Thread: Aprima is the only non-vein-specific EHR certified by the ACP (/showthread.php?tid=190)



Aprima is the only non-vein-specific EHR certified by the ACP - Margaret Kelly - 10-28-2016

American College of Phlebology Names Aprima aCertified ACP PRO Venous Registry EHR Vendor
 
Aprima is the only non-vein-specific EHR certified bythe ACP
 
Stop by Aprima Booth 513 at the 2016 ACP AnnualCongress to learn more
 
Dallas (October 27, 2016) – AprimaMedical Software, a leading provider of innovative electronic health records (EHR), practice management (PM) and revenue cycle management solutions (RCM) for medical practices, today announced that the American College of Phlebology (ACP) has certified that Aprima EHR has met certain minimum criteria, ensuring data fields match and provides a consistent interface between the user and the ACP PRO Venous Registry. (i)
 
“We are proud to be the first and onlynon-vein-specific EHR vendor to earn ACP certification,”
said Michael Nissenbaum, CEO andpresident of Aprima. “We have incorporated tools to make it easy for phlebology practices to document different types of treatments for specific vein conditions and have streamlined the reporting capabilities for the ACP Venous Registry. Aprima is committed to continually investing in our products and services to enhance their usage and to address the needs of current and future customers across a variety of specialties.”
 
The Aprima EHR is available withphlebology-specific forms to facilitate the documentation of a variety of vein-specific conditions. The Aprima solution also includes built-in support to help practices meet requirements for Medicare performance programs and quality reporting initiatives, including PQRS, Meaningful Use and the current 2017 MACRA/MIPS program.
 
“What I like about Aprima is the abilityto easily customize the system for my practice’s specific needs,” said Joseph T. Jenkins, M.D., F.A.C.S., of the Dubuque, Iowa Tri-State Vein Center. “Since the first day our practice went live all I have had to do was document procedures with a few clicks and I am done. The staff in my office have embraced Aprima EHR, which is important because my team is a vital part of the practice’s success.”
 
For a personal demo of Aprima, stop byour booth at the following upcoming conferences:
  • American College of Phlebology (ACP)Congress, Anaheim, CA, booth 513

  • Medical Group Management Association(MGMA), San Francisco, CA, booth 1107

  • American College of Rheumatology AnnualMeeting (ACR), Washington, DC, booth 1218

 
About Aprima Medical Software, Inc.
Aprima provides innovative electronichealth record, practice management and revenue cycle management solutions for medical practices. Throughout the company’s 18-year history, Aprima hasdelivered quality solutions that have helped thousands of users enhance patient care and satisfaction, as well as improve their practices’ bottom lines. The Aprima EHR/PM sets the benchmark for ease-of-use, speed, and flexibility, thanks to its single database and customizable design that adapts automatically to individual physician workflows. The Aprima solution has earned Certification for Meaningful Use Stage 2 and been awarded pre-validation status for NCQA PCMH recognition. The company is based in Richardson, Texas and performs all development, support and implementation from within the U.S. To learn more about how Aprima can help your practice, please visit http://www.aprima.com, call us at 844 4APRIMA or email us at info@aprima.com.
 
Aprima is a registered trademark ofAprima Medical Software. All other trademarks are the property of their respective owners.
 

(i) The ACP’s Certification of EMR/EHRcompanies is not an endorsement or certification of their product.